1. Products
  2. Solutions
  3. Insights+
  4. News & content
  5. About
-
  1. Products
  2. Solutions
  3. Insights+
  4. News & content
  5. About
  1. Launch

Pretzel Therapeutics, Inc.

Have updates for this profile?  Please contribute data

= Subscriber Access Only

You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.

With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.

Location

Waltham MA US

Primary Industry

Biotechnology

About

Based in Massachusetts, US, and founded by Michal Minczuk, Claes Gustafsson, Paul Thurk, and Nils-Göran Larsson, Pretzel Therapeutics, Inc., provides therapies to reverse mitochondrial dysfunction by mitochondrial biology. In September 2022, Pretzel Therapeutics, Inc., raised USD 72.5 million in series A funding led by investors, ARCH Venture Partners and Mubadala Capital, with participation from other investors Angelini Pharmaceuticals, Cambridge Enterprise, Eir Ventures, GU Ventures, GV, HealthCap, Invus, and Karolinska Institutet Holding AB. The company offers various mitochondrial therapeutic solutions that include genome correction, genome expression modulation, and mitochondrial quality control used for the treatment of mitochondrial dysfunction. The company used gene-editing tools, DNA replication, transcription, and translation to apply therapy for genetic disorders caused by mitochondrial mutations. The company plans to use the September 2022 funding to prosecute preclinical development and continue to build a talented team.
Current Investors
ARCH Venture Partners, HealthCap, Cambridge Enterprise

Request a demo to show more

Primary Industry
Biotechnology
Sub Industries
Molecular Science, Genetics & Gene Therapy
Website
www.pretzeltx.com
Company Stage
Series A
Total Amount Raised
Subscriber access only

Employee Data

Employee Graph

Want to see the Employee Count?

Request a demo for full access to this profile.

Time to go Pro

Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.